Investor Profile: LRVHealth — Thesis, Cheque Size & How to Apply

LRVHealth calls itself the “Inside Healthcare” venture capital platform — and the name is literal. Its network of strategic limited partners includes leading providers, payers and vendors and touches roughly half of all healthcare consumers in the US, and those partners are engaged alongside portfolio companies, not just behind the scenes. For founders researching how to get funding from LRVHealth, that is the whole pitch: capital plus an inside seat with the incumbents who buy, pilot and scale digital health products.

Founded in 2000 by healthcare investors, operators and advisers, the Boston-based firm invests exclusively in healthcare transformation. In March 2023 it announced LRVHealth Fund V, a $200 million fund focused on Care Anywhere — the shift of care delivery beyond hospital walls. Total assets under management are not publicly disclosed.

Thesis: what LRVHealth looks for

LRVHealth’s exclusive focus is forging partnerships between its strategic network members and entrepreneurs attacking healthcare’s biggest challenges. It applies industry knowledge and operating experience to early-stage companies, with a growing emphasis on Care Anywhere — home-based care, digital health and tech-enabled services that move care to where patients are. The firm is staffed by healthcare people using financial tools to solve healthcare problems, in its own phrasing: former operators and investors with decades inside the system.

Sectors and stage

Early-stage and venture-stage digital health, medical devices and diagnostics — the firm says it has provided the first institutional cheque to dozens of healthcare startups over two decades. Exact cheque sizes are not publicly disclosed, but the $200M Fund V and early-stage mandate fit the seed-through-Series-A profile typical of healthcare venture funds of that size. What it screens for is a product its provider and payer partners would pilot: transformation that serves both superior financial returns and positive health impact.

Notable portfolio and track record

LRVHealth’s legacy portfolio includes GetWellNetwork, Phreesia, lifeIMAGE, Convergent Dental and MedVentive. Recent portfolio testimonials come from a new generation of AI-enabled healthcare companies: Humata Health, whose founder calls the firm a value-add investor with deep health-system relationships; Greater Good Health; LucyRx, whose CEO credits LRVHealth’s deep connections and pulse on where the industry is headed; and ArcheHealth. The pattern is consistent: companies whose growth depends on enterprise buyers inside health systems — precisely what the platform delivers.

People and programmes

The firm is led by Managing Partner Keith Figlioli, joined as Managing Partner by Josh Flum, the former Chief Strategy Officer of CVS Health who launched CVS Health Ventures; Ellen Herlacher was promoted to Partner in 2023. The broader team includes operators from Providence Ventures, Optum and ChenMed, plus executive advisers drawn from the top of US healthcare — from former CMS administrators to health-system chief executives — who work with portfolio companies on strategy, go-to-market and scaling.

How to apply for funding from LRVHealth

There is no public application programme; founders reach the team through lrvhealth.com. The strongest entries come through its network: a pilot-ready product for a health system or payer partner, and a warm introduction from someone inside the healthcare ecosystem. If your product needs enterprise adoption to work, LRVHealth will judge the partnership fit as seriously as the product.